Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Hartadinata Abadi Tbk. (HRTA) vs UBC Medical Indonesia Tbk. (LABS)

Hartadinata Abadi Tbk.Trading
UBC Medical Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Hartadinata Abadi Tbk. dan UBC Medical Indonesia Tbk.: Hartadinata Abadi Tbk. diperdagangkan di Rp1.835 (kapitalisasi pasar 8,47 T, volume 24 jam 13,19 jt), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp146 (kapitalisasi pasar 584,6 M, volume 24 jam 817,3 rb). Perbedaan utamanya: Hartadinata Abadi Tbk. jauh lebih besar — sekitar 14,5× kapitalisasi pasar UBC Medical Indonesia Tbk., dan Hartadinata Abadi Tbk. lebih aktif diperdagangkan (13,19 jt vs 817,3 rb). Mana yang lebih baik tergantung tujuan investasimu.

HRTALABS
Kapitalisasi Pasar
8,47 T584,6 M
Volume
13,19 jt817,3 rb
Lot
131,91 rb8,17 rb
Perputaran
24,2 M120,01 jt
Harga Rata-rata
1.834,34146,84
Nilai Transaksi
24,2 M120,01 jt
Harga Ekuilibrium Indikatif
1.835146
Volume Ekuilibrium Indikatif
1,97 rb59

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

HRTA
Lihat detail
LABS
Lihat detail

Tentang Hartadinata Abadi Tbk.

PT Hartadinata Abadi Tbk (“the Company”) was established based on Notarial Deed No. 11 datedMarch 29, 2004 of Mayasari Soegiharto, S.H.

Selengkapnya di halaman HRTA

Tentang UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Selengkapnya di halaman LABS